Citation profile for Gisselle Gallego

Gisselle Gallego : Citation Profile

H index

i10 index

Citations

RESEARCH PRODUCTION:

Articles

Papers

RESEARCH ACTIVITY:

   5 years (2007 - 2012). See details.
   Cites by year: 5
   Journals where Gisselle Gallego has often published
   Relations with other researchers
   Recent citing documents: 1.    Total self citations: 1 (3.85 %)

MORE DETAILS IN:

EconPapers

ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pga336
   Updated: 2024-01-16    RAS profile: 2023-11-09
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Gisselle Gallego.

Is cited by:

Hall, Jane (2)

Viney, Rosalie (2)

Parkinson, Bonny (1)

Norman, Richard (1)

Haas, Marion (1)

Richardson, Jeff (1)

Sermet, Catherine (1)

Scuffham, Paul (1)

Prilepskiy, Ilya (1)

pinto-prades, jose-luis (1)

Cites to:

Lancsar, Emily (3)

Savage, Elizabeth (3)

Viney, Rosalie (3)

Tsuchiya, Aki (2)

Haas, Marion (2)

Small, Kenneth (2)

Heckman, James (2)

Rosen, Harvey (2)

Santos Silva, João (1)

Anderson, Richard (1)

Thursby, Jerry (1)

Main data

Where Gisselle Gallego has published?

Journals with more than one article published	# docs
Health Policy	3
PharmacoEconomics	3

Working Papers Series with more than one paper published	# docs
Working Papers / CHERE, University of Technology, Sydney	6

Recent works citing Gisselle Gallego (2024 and 2023)

Year	Title of citing document
2023	Criteria for the procedural fairness of health financing decisions: a scoping review. (2023). Gopinathan, U ; Dale, E ; Voorhoeve, Alex ; Ottersen, T ; Norheim, O ; Peacocke, E ; Movik, E. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:119799. Full description at Econpapers \|\| Download paper

Works by Gisselle Gallego:

Year	Title	Type	Cited
2011	Introduction and uptake of new medical technologies in the Australian health care system: A qualitative study In: Health Policy. [Full Text][Citation analysis]	article	2
2007	Priority setting for high cost medications (HCMs) in public hospitals in Australia: A case study In: Health Policy. [Full Text][Citation analysis]	article	12
2009	Funding and access to high cost medicines in public hospitals in Australia: Decision-makers perspectives In: Health Policy. [Full Text][Citation analysis]	article	3
	In: . [Full Text][Citation analysis]	article	0
2007	Incorporating economic evidence into cancer care: searching for the missing link In: Working Papers. [Full Text][Citation analysis]	paper	0
2008	A model for best practice HTA In: Working Papers. [Full Text][Citation analysis]	paper	0
2008	Equity weights for economic evaluation: An Australian Discrete Choice Experiment, CHERE Working Paper 2008/5 In: Working Papers. [Full Text][Citation analysis]	paper	2
2009	Framework for the cost benefit analysis of the NSW Department of Community Services Brighter Futures Program. CHERE Working Paper 2009/4. In: Working Papers. [Full Text][Citation analysis]	paper	0
2009	Evidence for funding, organising and delivering health care services targeting secondary prevention and management of chronic conditions. CHERE Working Paper 2009/6 In: Working Papers. [Full Text][Citation analysis]	paper	0
2010	Reducing the use of ineffective health care interventions. CHERE Working Paper 2010/5 In: Working Papers. [Full Text][Citation analysis]	paper	2
2007	Economic Evidence at the Local Level In: PharmacoEconomics. [Full Text][Citation analysis]	article	2
2012	Chemotherapy Administration In: PharmacoEconomics. [Full Text][Citation analysis]	article	2
2012	Chemotherapy Administration.(2012) In: PharmacoEconomics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 2	article